Über uns
Über uns
Führungsteam
Partnerschaften
Unsere Standorte
Technologie
Technologie
Produktion
Publikationen
Pipeline
Newsroom
News
Events
Downloads
Investor Relations
Überblick
Aktieninformation
Analysten-Coverage
Außerordentliche Hauptversammlung 2023
Finanzberichte
Corporate Governance
E-Mail Alert
Karriere
Werden Sie Teil der RNA people
Ausbildung
Aktuelle Stellenangebote
DE
Review Articles
mRNA: A novel Avenue to Antibody Therapy
by Sovereign
New Vaccine Technologies to Combat Outbreak Situations
by Sovereign
mRNA as novel technology for passive immunotherapy
by Sovereign
mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer
by Sovereign
A development, that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs
by Sovereign
A novel, disruptive vaccination technology, Self-adjuvanted RNActive® vaccines
by Sovereign
Developing mRNA-vaccine technologies
by Sovereign
mRNA: delivering an antitumor message
by Sovereign
Vaccination with messenger RNA
by Sovereign
RNA-based Therapies
by Sovereign
1
2
